BCL2 and early-onset autosomal dominant Alzheimer disease: In Aβ1–40-induced Alzheimer’s disease (AD), ginsenoside Rb1 inhibits the expression of BAX and caspase-3 in the hippocampus and increases the expression of BCl-2, thereby regulating the neuronal cell death pathway and preventing AD [69].